STAT3 and neoplasm: However, in tumor cells, 50%–90% of tumor cells exhibit sustained activation (LI et al., 2019) and in 66%–83% of GBM, the STAT3 pathway is constitutively activated (Carro et al., 2010; Kim et al., 2013).